The Market Analyzer
  • Business
  • Investing
  • Economy
  • Stock
Trending Now
PDAC 2026: Canada Doubles Down on Mining as...
Rick Rule: Gold Price During War, Silver Strategy,...
LITHIUM AFRICA CORP. ANNOUNCES UPSIZE IN PRIVATE PLACEMENT...
Alvopetro Announces February 2026 Sales Volumes
Chen Lin: Key Silver Date to Watch, My...
Lobo Tiggre: Gold, Oil in Times of War,...
Prismo Metals Closes Strategic Transaction with Blade Resources
Oreterra Metals
Oreterra Metals: Close on the Trail of a...
WPIC: Platinum Market Heading for Fourth Straight Deficit...

The Market Analyzer

  • Business
  • Investing
  • Economy
  • Stock
Investing

Chen Lin: Key Silver Date to Watch, My Favorite 2026 Commodities

by admin March 6, 2026
March 6, 2026
Chen Lin: Key Silver Date to Watch, My Favorite 2026 Commodities

Chen Lin of Lin Asset Management weighs in on silver and gold, as well as the critical minerals market, which is his favorite sector for 2026.

He also discusses how conflict in the Middle East could impact the resource sector.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Lobo Tiggre: Gold, Oil in Times of War, Plus My Shopping List Now
next post
Alvopetro Announces February 2026 Sales Volumes

Related Posts

Kobold to advance Konkola West Project Agreement to...

October 31, 2025

Kinetiko Commences Trading on North American OTC Market

December 23, 2025

Rising US-Venezuela Tensions,CPC Shutdown Push Oil Prices Higher

December 3, 2025

Kinetiko Energy: Developing South Africa’s Largest Onshore Natural...

February 10, 2026

Maiden Sampling Identifies District-Scale Critical Minerals System at...

January 16, 2026

Crypto Market Update: Bitcoin ETF Inflows Hit US$2.3...

September 16, 2025

Finlay Minerals Announces Closing of Non-Brokered Private Placement...

October 18, 2025

Aurum hits 0.8m @ 350 g/t gold at...

October 27, 2025

Trading Halt

August 25, 2025

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue...

November 11, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • PDAC 2026: Canada Doubles Down on Mining as Investment Attractiveness Score Peaks
    • Rick Rule: Gold Price During War, Silver Strategy, Oil Stock Game Plan
    • LITHIUM AFRICA CORP. ANNOUNCES UPSIZE IN PRIVATE PLACEMENT TO C$8.5M WITH LEAD ORDER FROM PURPOSE GLOBAL RESOURCE FUND
    • Alvopetro Announces February 2026 Sales Volumes
    • Chen Lin: Key Silver Date to Watch, My Favorite 2026 Commodities

    Popular Posts

    • 1

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 2

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

      April 21, 2025
    • 3

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

      July 28, 2025
    • 4

      Elon Musk confirms Tesla has signed a $16.5 billion chip contract with Samsung Electronics

      July 29, 2025
    • 5

      Recall warns some Celsius energy drink cans accidentally contain alcohol

      July 31, 2025

    Categories

    • Business (131)
    • Economy (20)
    • Investing (1,561)
    • Stock (20)
    Footer Logo
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: themarketanalyzer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 themarketanalyzer.com | All Rights Reserved